HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses
Year: 2025
Type: article
Source: Journal of Hepatology
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Tianjin Medical University, Fundamental Research Funds for the Central Universities, National Major Science and Technology Projects of China, National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology, Program for Jilin University Science and Technology Innovative Research Team
OpenAlex ID: W4415313016
